Search

everythinglearnresearchcommunity

for

Search:↓

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

A rare, non-cancerous ovarian tumor was successfully treated with surgery, improving the patient's symptoms.

Therapies targeting the androgen receptor are being developed to treat prostate cancer and improve bone and muscle health.

The document describes a treatment for excessive hair growth in a teenage girl using medication and birth control, but does not report the results.

The discovery of 5α-reductase deficiency in guevedoces led to the development of important urologic medications.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

Testosterone therapy in transgender men can lead to hair loss, with the risk increasing over time and influenced by family history.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

In post-menopausal women, signs of increased male hormones should be checked for possible ovarian cancer.

Antiandrogens can treat excess body hair and hair loss by blocking male hormones.

Testosterone treatment may change estrogen receptor methylation in AFAB individuals.

A postmenopausal woman's high testosterone levels and symptoms improved after removing a tumor from her ovary.

A woman's male-like symptoms and high testosterone were due to ovarian hilus-cell hyperplasia, which improved after surgery.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

Daily subcutaneous testosterone effectively restores testosterone levels in men.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

Ovarian steroid cell tumors should be considered in adults with hirsutism and high testosterone, with surgery as the main treatment.

Topical finasteride may help treat facial hirsutism in women.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

The document concludes that managing female hyperandrogenism requires a combination of identifying the cause, lifestyle changes, medication, and cosmetic treatments.

Hormonal therapies are safe and effective for treating acne in female adolescents, with specific treatments for those with endocrine disorders.

Finasteride may improve prostate cancer therapy by enhancing testosterone's benefits and reducing risks.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

A postmenopausal woman's facial redness, acne, and excess hair were caused by too much hormone therapy for insomnia, but improved after stopping the treatment.

Masculinization in affected individuals occurs gradually after puberty due to hormone changes.

Properly administered testosterone therapy is safe and effective but often not covered by insurance.

A woman's adrenal tumor disappeared after treatment with cyproterone acetate.